Johns Hopkins Medicine Office of Continuing Medical Education
Course Calendar Programs Registration Faculty Online Post Tests Home
Contact us
Traveling to CME
Answers to your questions
Resources for planners
About JHU CME
CME Online
Find a course

Advanced search
 
 
   
   Click here to participate in this program

Selective Adhesion Molecule (SAM) Inhibitors in Multiple Sclerosis

Course Director: Peter Calabresi, MD
August 13, 2004 - August 13, 2005


While current disease modifying therapies in multiple sclerosis are effective, many patients experience breakthrough and relapses while on treatment. As newer therapeutics utilizing selective adhesion molecule (SAM) inhibition for multiple sclerosis (MS) enter clinical trials and approach approval, physicians and health care professionals need to understand the basic science regarding these new therapeutic agents and their mechanisms of action. This multimedia course reviews current treatment needs in multiple sclerosis management and possible improvements via selective adhesion molecule (SAM) inhibition. Basic science behind current SAM inhibitors is presented, providing healthcare professionals a chance to familiarize themselves with this emerging area of therapeutics.

Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physicians' Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Click here to participate in this program

   

 

©2002-2004, Johns Hopkins University, School of Medicine, Office of Continuing Medical Education
Privacy statement | Website design: Kim Bieler Graphic Design